Reports for TEVA-SUCRALFATE
Brand name
TEVA-SUCRALFATE
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02045702 |
Ingredients
SUCRALFATE |
Ingredient Strength
1 G |
ATC Code
A02BXA02BX |
ATC Descriptor
DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
TEVA-SUCRALFATE | 100 | Actual shortage | 2024-03-07 | 2024-04-05 | 221540 |
TEVA-SUCRALFATE | 500 | Actual shortage | 2023-12-14 | 2024-02-22 | 213368 |
TEVA-SUCRALFATE | 100 | Resolved | 2023-06-16 | 2023-10-04 | 195055 |
TEVA-SUCRALFATE | 500 | Resolved | 2023-08-17 | 2023-10-04 | 202228 |
TEVA-SUCRALFATE | 500 | Resolved | 2023-07-27 | 2023-08-04 | 200210 |
TEVA-SUCRALFATE | 500 | Resolved | 2023-06-16 | 2023-07-21 | 195039 |
TEVA-SUCRALFATE | 500 | Resolved | 2023-02-16 | 2023-06-09 | 184934 |
TEVA-SUCRALFATE | 100 | Resolved | 2022-06-09 | 2022-09-08 | 162303 |
TEVA-SUCRALFATE | 100 | Resolved | 2022-01-27 | 2022-02-25 | 153727 |
TEVA-SUCRALFATE | 500 | Resolved | 2021-12-17 | 2022-01-20 | 151468 |
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0